Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days In Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Pharmacokinetically Similar to Q6 Hour Dosing in the Pediatric Population

Autor:	Leslie M. Shaw, R. Hawks, M.B. Bradley, I. Waxman, Diane George, Mitchell S. Cairo, Monica Bhatia, O. Militano, Prakash Satwani, James Garvin, Michael C. Milone, Joseph E. Schwartz, K. Wolownik, C. van de Ven, Virginia Moore, B. Tallamy, S. Foley, L.A. Baxter-Lowe
Jazyk:	angličtina
Předmět:	Oncology Transplantation medicine.medical_specialty business.industry medicine.medical_treatment Hematology Hematopoietic stem cell transplantation Internal medicine medicine Dosing business Busulfan medicine.drug Pediatric population
Zdroj:	Biology of Blood and Marrow Transplantation. (2):74
ISSN:	1083-8791
DOI:	10.1016/j.bbmt.2008.12.229
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5073a9e1e7939994803cb60bc5e6646 Zobrazit plný text záznamu